The -Rest Of Europe Gastrointestinal Products Market was valued at $371.9 Million in 2024 and projected to reach to $489.1 Million by 2029, representing a compound annual growth rate of 5.6%. Rest of Europe's gastrointestinal products market is poised for steady expansion, driven by demographic shifts, increased awareness of digestive health, and improved healthcare infrastructure across smaller European nations.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest of Europe's gastrointestinal products market is valued at $371.9 million in 2024, with a projected CAGR of 5.6% through 2029, reaching $489.1 million by forecast end.
Increasing prevalence of digestive disorders across Rest of Europe countries, combined with rising healthcare expenditure and improved access to treatment options, is fueling market expansion.
Rest of Europe represents a key regional segment within the broader European healthcare landscape, with distinct market dynamics and growth opportunities compared to major EU markets.
The market is expected to grow from $371.9 million to $489.1 million between 2024-2029, demonstrating consistent demand for gastrointestinal therapeutic solutions in the region.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | IRRITABLE BOWEL SYNDROME (IBS) (Disease) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 6.1% from 2024 to 2029 |
| Largest Segment | ENDOSCOPY DEVICES (Device) |
| Market Size Base Year (Billions) | ~USD 14.65 (2024) |
| Revenue Forecast (Billions) | ~USD 19.7 (2029) |
| Segments Covered | Device, Type, Disease, End User |
4 segment dimensions are covered across the global market.
-Rest Of Europe's gastrointestinal products market is estimated at $371.9 million in 2024, based on verified market data.
-Rest Of Europe's gastrointestinal products market is forecast to reach $489.1 million by 2029, representing significant regional growth.
-Rest Of Europe's gastrointestinal products market is expected to grow at a compound annual growth rate of 5.6% from 2024 to 2029.
-Rest Of Europe's market growth is driven by an aging population, increasing GI disorder prevalence, rising healthcare awareness, and improved product accessibility.
-Rest Of Europe's 5.6% CAGR is slightly below the global average of 6.1%, indicating steady but measured regional growth relative to worldwide market expansion.
The study involved four major activities to estimate the current size of the gastroenterology products market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Gastrointestinal Products Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Extensive primary research was conducted after obtaining information regarding the Gastroenterology Products Market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the gastrointestinal products market.; and key opinion leaders.
Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market. the following is a breakdown of the primary respondents:

To know about the assumptions considered for the study, download the pdf brochure
The research methodology used to estimate the size of the gastrointestinal products market includes the following details. The market sizing of the market was undertaken from the global side.
The size of the gastrointestinal products market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall gastrointestinal products market was obtained from secondary data and validated by primary participants to arrive at the total gastroenterology products market. Primary participants further validated the numbers.
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Gastroenterology/Gastrointestinal Products Market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.


To know about the assumptions considered for the study, Request for Free Sample Report
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the gastrointestinal products market.
Gastroenterology products encompass a variety of medical devices, diagnostic tools, and pharmaceuticals designed to diagnose, treat, and manage diseases and disorders of the gastrointestinal tract. These products include endoscopes, capsule endoscopy systems, ablation devices, stents, and specialized medications aimed at conditions like GERD, IBD, and colorectal cancer. Their purpose is to improve patient outcomes by offering advanced solutions for both diagnostic and therapeutic procedures within the GI tract.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Gastrointestinal Products Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report